Company | Cap $ | P/E | P/B | P/S | ROE | ROA | ROS | L/A | P/FCF | PR | Period |
---|---|---|---|---|---|---|---|---|---|---|---|
2seventy bio | 229 | 2023q3 | |||||||||
AbbVie | 293,959 | 2023 | |||||||||
AbCellera Biologics | 783 | 2023q3 | |||||||||
Abeona Therapeutics | 95 | 2022 | |||||||||
ACADIA Pharmaceuticals | 3,566 | 2023q1 | |||||||||
Achilles Therapeutics | 40 | 2023q3 | |||||||||
Adaptive Biotechnologies | 621 | 2023q3 | |||||||||
ADC Therapeutics | 121 | 2023q2 | |||||||||
ADMA Biologics | 5,111 | 2023q3 | |||||||||
Affimed | 434 | 2021 | |||||||||
Agilent Technologies | 41,656 | 2023q1 | |||||||||
Agios Pharmaceuticals | 1,633 | 2022 | |||||||||
Alector | 436 | 2023q2 | |||||||||
Allakos | 121 | 2023q3 | |||||||||
Allogene Therapeutics | 500 | 2023q3 | |||||||||
Alnylam Pharmaceuticals | 33,795 | 2022 | |||||||||
Amarin Corporation | 351 | 2023q2 | |||||||||
Amgen | 136,845 | 2023q3 | |||||||||
Amicus Therapeutics | 3,293 | 2021 | |||||||||
AnaptysBio | 576 | 2023q3 |